Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System

...then 10 years later we defined how important the #systemic effects of #GLP1 (Glucagon-like peptide 1) were for #aging/#neurodegeneration.... https://t.co/66doBAnpEF

If you'd like to read more about our work demonstrating how therapeutic control of Glucagon-like peptide 1 (GLP-1) receptors can exert a systemic therapeutic action in multiple debilitating neurodegnerative disorders then here's a link for you! - https://t

Great to see our work on defining effective drug targets, e.g. the GLP-1 receptor, to control multiple neurodegenerative diseases has reached so many people ! (5000 views and counting....) https://t.co/Sl55G9rjmW https://t.co/zB2HDdXVnF

PubMed: Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1... http://t.co/O7nN6oogvc